Abstract

We retrospectively analyzed the prognostic significance of preoperative serum Krebs von den Lungen-6 (KL-6) surfactant protein-D (SP-D) levels in non-small cell lung cancer (NSCLC) patients with interstitial pneumonia (IP). We enrolled 41 NSCLC patients with IP who have undergone curative surgery. Prognostic significance of serum KL-6 and SP-D levels was examined. We found a significant relationship between serum KL-6 and SP-D levels in NSCLC patients with IP. However, the 5-year survival of patients with high serum KL-6 level was poor, whereas serum SP-D level was not related to patients’ survival. Univariate analysis revealed that there was a trend towards an association between serum KL-6 level and patients’ prognosis but this did not reach statistical significance. This might be due to small number of study patients. In conclusion, there is a possibility that serum KL-6 level is a prognostic marker regardless of the presence of IP.

Highlights

  • We retrospectively analyzed the prognostic significance of preoperative serum Krebs von den Lungen-6 (KL-6) surfactant protein-D (SP-D) levels in non-small cell lung cancer (NSCLC) patients with interstitial pneumonia (IP)

  • We found a significant relationship between serum KL-6 and SP-D levels in NSCLC patients with IP

  • There is a possibility that serum KL-6 level is a prognostic marker regardless of the presence of IP

Read more

Summary

Introduction

Some previous studies showed that serum KL-6 level is useful for predicting survival of non-small cell lung cancer (NSCLC) patients who have undergone curative surgery [6] [7]. It has not been known whether NSCLC patients with IP might have higher serum levels of KL-6. Only a few study examined the prognostic significance of serum KL-6 level in NSCLC patients with IP [8] [9]. Miyazaki et al [8] reported the prognostic significance of serum KL-6 levels in lung cancer patients with or without IP. Our previous study showed the similar findings [9], but the number of patient with IP was very small (only 14 patients)

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.